Last reviewed · How we verify
Ketones
At a glance
| Generic name | Ketones |
|---|---|
| Sponsor | Massachusetts General Hospital |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants (PHASE1)
- Nutritional Ketosis Marfan (NA)
- Methadone Pharmacokinetics in Cardiac Surgery (PHASE4)
- Urine and Ultrasound Screening for Kidney Disease in Children (NA)
- Short Term Ketone Supplementation and Cardiometabolic Health (NA)
- Effect of Nutritional Ketosis on Alcohol Metabolism (PHASE2, PHASE3)
- Effects of Ketone Supplement and Alcohol on Brain Metabolism (PHASE2, PHASE3)
- Exogenous Ketosis and Muscle Protein Synthesis During Exercise Recovery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ketones CI brief — competitive landscape report
- Ketones updates RSS · CI watch RSS
- Massachusetts General Hospital portfolio CI